アストラゼネカワクチン
アストラゼネカワクチンの論文
Lancet
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M Folegatti, MSc *
Lancet
ARTICLES| VOLUME 396, ISSUE 10249, P467-478, AUGUST 15, 2020
Open AccessPublished:July 20, 2020DOI:https://doi.org/10.1016/S0140-6736(20)31604-4
Nature, NEWS 23 NOVEMBER 2020
Why Oxford’s positive COVID vaccine results are puzzling scientists
Preliminary data suggest that the immunization was more effective in trial participants who received a lower dose.
- 最終更新:2020-12-08 17:36:07